4-(5-FLUORO-1H-INDOL-3-YL)-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 97.0%, 250mg

2,4-Pyridinedicarboxylic Acid>98.0%(GC)(T)5g

2-Bromo-6-(trifluoromethyl)pyridine>98.0%(GC)5g

N,N-Bis(2-chloroethyl)-4-methylbenzenesulfonamide, 97.0%, 10g

(2-(Difluoromethyl)phenyl)boronic acid, 97%, 100mg

2-Bromoanthraquinone>96.0%(GC)5g

HPLC column NUCLEODUR® 100-3 C18 ec 3 µm, 150 mm, 4.6 mm, 1 Piece(s)

7-Bromobenzo[c][1,2,5]thiadiazole-4-carbaldehyde, 97.0%, 5g

4-(4-Acetyl-phenoxy)-butyric acid, 25g

trans,trans-4'-Butyl-4-(3,4-difluorophenyl)bicyclohexyl>98.0%(GC)25g

(R)-Ethyl 4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 97%, 250mg

2-(2,2,2-Trifluoroethoxy)pyridin-3-amine, 97%, 1g

tert-Butyl 4-[(5-nitropyridin-2-yloxy)methyl]piperidine-1-carboxylate, 95.0%, 1g